- Home
- TRIB vs COEP Comparison
TRIB vs COEP Comparison
Compare TRIB & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- COEP
- Stock Information
- Founded
- TRIB 1992
- COEP 2017
- Country
- TRIB Ireland
- COEP United States
- Employees
- TRIB N/A
- COEP N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRIB Health Care
- COEP Health Care
- Exchange
- TRIB Nasdaq
- COEP Nasdaq
- Market Cap
- TRIB 25.5M
- COEP 30.5M
- IPO Year
- TRIB N/A
- COEP N/A
- Fundamental
- Price
- TRIB $0.59
- COEP $9.48
- Analyst Decision
- TRIB
- COEP
- Analyst Count
- TRIB 0
- COEP 0
- Target Price
- TRIB N/A
- COEP N/A
- AVG Volume (30 Days)
- TRIB 37.2K
- COEP 42.3K
- Earning Date
- TRIB 05-22-2025
- COEP 05-09-2025
- Dividend Yield
- TRIB N/A
- COEP N/A
- EPS Growth
- TRIB N/A
- COEP N/A
- EPS
- TRIB N/A
- COEP N/A
- Revenue
- TRIB $59,126,000.00
- COEP N/A
- Revenue This Year
- TRIB $11.63
- COEP N/A
- Revenue Next Year
- TRIB $10.13
- COEP N/A
- P/E Ratio
- TRIB N/A
- COEP N/A
- Revenue Growth
- TRIB N/A
- COEP N/A
- 52 Week Low
- TRIB $0.56
- COEP $2.31
- 52 Week High
- TRIB $3.55
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- TRIB 36.73
- COEP 45.50
- Support Level
- TRIB $0.56
- COEP $9.01
- Resistance Level
- TRIB $0.71
- COEP $9.75
- Average True Range (ATR)
- TRIB 0.04
- COEP 0.84
- MACD
- TRIB -0.01
- COEP -0.03
- Stochastic Oscillator
- TRIB 15.62
- COEP 46.07
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.